BMJ
February 23, 2026
Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle et al.
5 citations
Over the past 15 years, psychedelic treatments have garnered substantial clinical interest, with psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) advancing to phase 3 trials for various psychiatric conditions. This state-of-the-art review examines the evidence for these treatments and their proposed mechanisms of action, and identifies key challenges in clinical translation. Psychedelic...
Harm Reduction Journal
February 14, 2026
Camilo Obregón-berg, Bruno Fuentealba-Donoso, Isidora Vidal et al.
The health risks for people who use drugs (PWUD) in Chile are exacerbated by evolving drug markets, unpredictable supplies, and the limited availability of harm reduction services. Community-based drug-checking programs have shown effectiveness in reducing some of these risks; however, regional evidence remains limited. In 2024, Reduciendo Daño (RD), a Chilean non-profit organization, conducted...
Lebenswelt: Aesthetics and Philosophy of Experience
February 13, 2026
Marcello Ghilardi
The paper explores the relationship between silence and speech, highlighting the coexistence and mutual implication of these two seemingly opposite poles. Silence is explored in various senses: as the source from which speech springs; as the absence of voice that can arise from an unspeakable experience of pain or ecstasy; as a dimension of meditation and deep listening, necessary to embrace...
Open Mind
February 13, 2026
John Moriarty, Alan Robert Bowman, Alison Pocock
preprint
Psychedelics are psychoactive substances that alter one's perception, cognition and emotion, as well as one's sense of time, place and self (Nutt, 2023, p.19). Psychedelic-assisted therapy (PAT) involves the carefully controlled administration of a psychedelic substance "alongside structured psychological support, including preparation, guidance during the psychedelic session, and post-session...
Journal of Education College Wasit University
February 10, 2026
Asst.Prof. Hameed Mana Daikh
تتناول الورقة البحثية رواية وليام غيبسون نيورومانسر (1984) كنص مهم في دراسات الأدب ما بعد الإنساني، وتحلل كيف تتصور الرواية تطور الوعي ما وراء القيود الإنسانية التقليدية. و تستكشف هذه الدراسة استناداً إلى نظرية ما بعد الإنسانية، وبخاصة أعمال ن. كاثرين هايلز وروزي برايدوتي، عرض غيبسون لنماذج متعددة للوعي ما بعد الإنساني من خلال شخصيات رئيسية: الوعي الرقمي المجرد لـ"كيس"، والذكاء الاصطناعي...
Nervenheilkunde
February 1, 2026
Dimitris Repantis, Michael Koslowski, Felix Betzler et al.
Zusammenfassung Psychedelika wie Psilocybin und LSD durchlaufen eine bemerkenswerte Geschichte, die von frühen psychiatrischen Anwendungen über den Freizeitgebrauch und die Prohibition in den 70er Jahre bis zur aktuellen Wiederentdeckung in klinischen Studien reicht. MDMA wird seit etwa 15 Jahren für die Behandlung der posttraumatischen Belastungsstörung evaluiert. In der Behandlung werden...
The Journal of Sexual Medicine
February 1, 2026
Hendrikus Knegtering, Thalia Herder, Nynke Boonstra et al.
Psychedelic-assisted therapy (PAT) is increasingly investigated as a treatment for depression, post-traumatic stress disorder (PTSD), and substance use disorder. In the United States (US) and European Union, esketamine has been approved for the treatment of depression, while psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) have received Breakthrough Therapy Designation in the US for...
Neuroscience & Biobehavioral Reviews
February 1, 2026
Mallet R Reid, Jonathan Song, Kevin F. Boehnke et al.
People of color have been significantly underincluded in psychedelic-assisted therapy (PAT) research, despite facing challenges commonly addressed in PAT and often more severe symptoms. It may be the case that people of color are underincluded because PAT researchers have not used approaches designed to promote sample diversity. Community-engaged research (CEnR) is a research paradigm that has...
Brain and Behavior
February 1, 2026
Simon Halm
1 citation
Psychedelic- and substance-assisted therapies, including MDMA, psilocybin, and ketamine, are gaining attention for conditions such as PTSD and depression, yet their development and implementation remain largely concentrated in high-income settings. This graphical abstract summarizes the central argument of the commentary: while these interventions may hold relevance for global mental health,...
AIDS and behavior
January 27, 2026
I Pastor, M A Kundro, M Alonso Serena et al.
Chemsex, defined as the intentional use of psychoactive substances to enhance sexual activity, has been associated with a higher frequency of sexually transmitted infections (STIs) diagnosis among HIV pre-exposure prophylaxis (PrEP) users. Evidence from Latin America remains limited. This research aims to characterize the practice of chemsex and STIs prevalence in PrEP users in Buenos Aires,...